Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets closed

S&P 500
5,998.74
-22.89(-0.38%)
Dow 30
44,722.06
-138.25(-0.31%)
Nasdaq
19,060.48
-115.10(-0.60%)
Russell 2000
2,426.19
+1.88(+0.08%)
Crude Oil
68.88
+0.16(+0.23%)
Gold
2,639.70
-0.20(-0.01%)

Glenmark Life Sciences Limited (GLS.NS)

NSE - NSE Real Time Price. Currency in INR

Follow

1,080.60

-2.20

(-0.20%)

At close: 03:30PM IST

Currency in INR

Valuation Measures⁴

Market Cap (intraday)	132.61B
Enterprise Value	127.47B
Trailing P/E	31.42
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	6.32
Price/Book (mrq)	5.23
Enterprise Value/Revenue	6.05
Enterprise Value/EBITDA	20.34

Trading Information

Stock Price History

Beta (5Y Monthly)	0.16
52-Week Change ³	71.85%
S&P500 52-Week Change ³	31.33%
52 Week High ³	1,335.10
52 Week Low ³	624.60
50-Day Moving Average ³	1,095.89
200-Day Moving Average ³	935.12

Share Statistics

Avg Vol (3 month) ³	258.7k
Avg Vol (10 day) ³	94.43k
Shares Outstanding ⁵	122.53M
Implied Shares Outstanding ⁶	122.6M
Float ⁸	30.63M
% Held by Insiders ¹	76.43%
% Held by Institutions ¹	6.64%
Shares Short ⁴	N/A
Short Ratio ⁴	N/A
Short % of Float ⁴	N/A
Short % of Shares Outstanding ⁴	N/A
Shares Short (prior month ) ⁴	N/A

Dividends & Splits

Forward Annual Dividend Rate ⁴	43.5
Forward Annual Dividend Yield ⁴	3.71%
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	65.29%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	Oct 17, 2023
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Mar 31, 2024
Most Recent Quarter (mrq)	Sep 30, 2024

Profitability

Profit Margin	19.21%
Operating Margin (ttm)	23.53%

Management Effectiveness

Return on Assets (ttm)	11.43%
Return on Equity (ttm)	17.18%

Income Statement

Revenue (ttm)	22.05B
Revenue Per Share (ttm)	179.94
Quarterly Revenue Growth (yoy)	-14.90%
Gross Profit (ttm)	N/A
EBITDA	6.03B
Net Income Avi to Common (ttm)	4.24B
Diluted EPS (ttm)	34.43
Quarterly Earnings Growth (yoy)	-19.70%

Balance Sheet

Total Cash (mrq)	4.46B
Total Cash Per Share (mrq)	36.43
Total Debt (mrq)	159.77M
Total Debt/Equity (mrq)	0.63%
Current Ratio (mrq)	4.52
Book Value Per Share (mrq)	207.20

Cash Flow Statement

Operating Cash Flow (ttm)	4.17B
Levered Free Cash Flow (ttm)	2.01B